Today, Feb. 28, is #RareDiseaseDay. We're proud to stand with the 400 million people worldwide living with a rare disease, their families and their care partners. At Parexel, we're committed to raising awareness and driving change. ? ??♀???♂???♀? For the third consecutive year, over 300 Parexel colleagues globally participated in the SYNGAP Elternhilfe e.V. Rare Diseases Run! We walked, ran, rolled and cycled to support rare disease research and patients. ? ?? Take a virtual tour with Team Parexel as we unite across the globe for this important cause: spreading awareness, supporting research and working toward better treatments for patients.
关于我们
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: ? Abusive, harassing or threatening to others. ? Defamatory, offensive, obscene, vulgar or depicting violence. ? Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. ? Sexually explicit or pornographic. ? Fraudulent, deceptive, libelous, misleading or unlawful. ? Referencing criminal or illegal activity. ? Spamming. We reserve the right to remove any comments that do not adhere to our guidelines as well as report users who violate the rules of our page.
- 网站
-
https://www.parexel.com
精鼎医药的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Durham,North Carolina
- 类型
- 私人持股
- 领域
- Regulatory and product development consulting、early phase clinical research、phase II-III clinical research、late phase clinical research、eClinical solutions、patient and site recruitment、medical device consulting、clinical research organization、pharmacovigilance、biotechnology、biotech和market access
地点
-
主要
2520 Meridian Pkwy
US,North Carolina,Durham,27713
精鼎医药员工
动态
-
Pharmacovigilance is crucial for maintaining post-marketing licenses. At Parexel, we have completed more than 2,000 post-marketing engagements. Our experts have global experience and can provide the comprehensive services you need. Learn more about our experience and services ??: https://lnkd.in/eRCacuNQ #DrugSafefy #Pharmacovigiliance
-
-
Antibody-drug conjugates (ADCs) are transforming cancer treatment by delivering targeted therapies with greater precision and fewer off-target effects than traditional chemotherapy. With nearly 100 ADCs currently in clinical development, the potential is enormous - but so are the complexities of regulatory approval, CMC challenges and clinical optimization. In this edition of the New Medicines, Novel Insights newsletter, Parexel experts and former regulators explore the evolving landscape of ADC development. From regulatory strategies to clinical best practices, we discuss how a thoughtful, multi-perspective approach can help bring these groundbreaking treatments to patients faster. Read the full article to learn more about the challenges and opportunities in ADC development. #ADC #Oncology #DrugDevelopment #NovelInsights
-
Parexel CEO Peyton Howell is in the hot seat for the new season of NYSE's The Cure(ious)!??? Follow along as top leaders and thinkers in the life sciences industry share career insights, personal wisdom and their visions for the future of healthcare. Three questions. Three bowls. One mission: to inspire and spark curiosity in health innovation. Find out what makes them curious: https://lnkd.in/eRMjFJnX ?? credit to NYSE #TheCurious #NYSE
-
Innovations that accelerate clinical trials are now commonplace in oncology and other therapeutic areas, yet neuroscience trials remain primarily traditional due to disease heterogeneity and the absence of actionable biomarkers. In this article from our latest report, Parexel experts Andreas Lysandropoulos MD, PhD, Simona Stankeviciute and Amy Pace review recent advances in the clinical research field that suggest the time has come for invention and cross-fertilization that promise to accelerate neuroscience drug development. Learn more here: ?? https://lnkd.in/eGPcRFjd #Neuroscience #Neurology #Innovation #NovelInsights
-
This month, our Black Employees Advisory Consortium (BEACON) came together to honor and celebrate U.S. Black History Month. ?? ? BEACON, now 260+ members strong, has been driving positive change over the past four years by: ? Fostering inclusion within Parexel ? Promoting patient access and representation in clinical research ? Supporting Black Women In Clinical Research ? events ? Engaging in local community service This month, BEACON also hosted a virtual book club discussion on "The Pact: Three Young Men Make a Promise and Fulfill a Dream," as well as an educational Lunch & Learn for colleagues on how to drive meaningful change in how medicine is taught and practiced. #BlackHistoryMonth #ClinicalResearch #ProudToBeParexel
-
-
We're only beginning to see the full potential of AI in clinical research. From optimizing clinical trial design, simplifying complex tasks and accelerating timelines, AI is transforming the way we work – helping us move faster, think bigger and collaborate more effectively. ? This week, we spoke with Jacqueline Vanderpuye-Orgle, Vice President and Global Head of Advanced Analytics at Parexel, about the multifaceted role AI plays in trials and evidence generation today – and what the future holds. ? Click through to see Jackie's insights on how AI is shaping the industry and accelerating the path to better patient outcomes. ? #AIandMe #ArtificialIntelligence #ClinicalResearch #HEOR #RWE
-
Looking for a role in clinical operations? Nirmallya started as a Senior Clinical Research Associate (CRA) during a critical phase of Parexel's India operations. As Parexel established its clinical research presence in India, Nirmallya's role evolved. He progressed to leading a team of Clinical Operations Leaders, fostering a culture of trust and empowerment along the way. Learn more about his career path and the opportunities for growth in clinical operations: https://brnw.ch/21wQSAb #ParexelCareers #ClinicalOperations
-
-
Meet Parexel's Michelle Major, who leads hiking groups, volunteers in canoe sprinting and aims to officiate at the 2032 Brisbane Olympics! Her life took an unexpected turn in 2021 when mysterious symptoms emerged which led to a diagnosis of an undefined autoimmune disease. ? Read her story and share this post to help us amplify patient voices like Michelle's. Q: Can you describe your rare disease journey? Late in 2021, I developed severe fatigue, an unusual rash, gastrointestinal symptoms and constant joint pain. It was big change of function from competing in a Half Ironman triathlon earlier that year. I was not used to being unwell and was not a very "patient" patient. After 18 months of various medications, I was referred to an immunology tertiary hospital. While they could not diagnose with precision, they prescribed a medication frequently used in immune-related conditions. So far, so good. Q: Why is self-advocacy important? Particularly when working through so many variable and bizarre symptoms, monitoring your own health is key. Each specialist is looking at a different aspect of your health, so you must share the whole you and know your body the best. When asked about advice for others seeking an official diagnosis, Michelle said: ?? Perseverance is key as you are moved from specialist to specialist ?? Keep track of your symptoms and the impact of medication to report as accurately as possible ?? Celebrate short-term success and appreciate that whilst you won't always have a clear path of progress, you can embrace the now. #RareDiseaseDay
-
-
We are proud nominees in the upcoming Vaccine Industry Excellence (ViE) Awards for "Best Clinical Trial Network" and "Best Contract Research Organization." Please consider casting your vote for Parexel before Feb. 24! ??https://brnw.ch/21wQQ5w #ViEAwards
-